NO159852C - Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion.

Info

Publication number
NO159852C
NO159852C NO834057A NO834057A NO159852C NO 159852 C NO159852 C NO 159852C NO 834057 A NO834057 A NO 834057A NO 834057 A NO834057 A NO 834057A NO 159852 C NO159852 C NO 159852C
Authority
NO
Norway
Prior art keywords
indion
piperid
preparation
active derivatives
therapeutic active
Prior art date
Application number
NO834057A
Other languages
English (en)
Norwegian (no)
Other versions
NO834057L (no
NO159852B (no
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO834057L publication Critical patent/NO834057L/no
Publication of NO159852B publication Critical patent/NO159852B/no
Publication of NO159852C publication Critical patent/NO159852C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO834057A 1982-11-08 1983-11-07 Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion. NO159852C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (3)

Publication Number Publication Date
NO834057L NO834057L (no) 1984-05-09
NO159852B NO159852B (no) 1988-11-07
NO159852C true NO159852C (no) 1989-02-15

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834057A NO159852C (no) 1982-11-08 1983-11-07 Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion.

Country Status (29)

Country Link
US (1) US4721710A (cs)
EP (1) EP0110755B1 (cs)
JP (1) JPS59161377A (cs)
KR (1) KR900006721B1 (cs)
AT (1) ATE22561T1 (cs)
AU (1) AU565519B2 (cs)
CA (1) CA1221967A (cs)
CS (1) CS244681B2 (cs)
DD (3) DD229407A5 (cs)
DE (1) DE3366623D1 (cs)
DK (1) DK511383A (cs)
ES (1) ES8406070A1 (cs)
FI (1) FI79536C (cs)
FR (1) FR2535721A1 (cs)
GR (1) GR78747B (cs)
HU (1) HU191494B (cs)
IE (1) IE56209B1 (cs)
IL (1) IL70099A (cs)
MA (1) MA19948A1 (cs)
NO (1) NO159852C (cs)
NZ (1) NZ206177A (cs)
OA (1) OA07582A (cs)
PH (1) PH20421A (cs)
PL (3) PL140021B1 (cs)
PT (1) PT77607B (cs)
SG (1) SG1989G (cs)
SU (3) SU1333237A3 (cs)
YU (3) YU221183A (cs)
ZA (1) ZA838065B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
PL2710007T3 (pl) 2011-05-17 2020-06-01 The Regents Of The University Of California Inhibitory kinazy
AU2012255860C1 (en) 2011-05-17 2015-12-10 Principia Biopharma Inc. Tyrosine kinase inhibitors
EP3181567B1 (en) 2012-09-10 2019-03-20 Principia Biopharma Inc. Pyrazolopyrimidine compounds as kinase inhibitors
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
MX372673B (es) 2014-02-21 2020-03-25 Principia Biopharma Inc Un inhibidor de btk para usarse en el tratamiento de penfigo y sales y formas sólidas del mismo.
SG11201704808VA (en) 2014-12-18 2017-07-28 Principia Biopharma Inc Treatment of pemphigus
US20180305350A1 (en) 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN109600989B (zh) 2016-06-29 2022-11-04 普林斯匹亚生物制药公司 2-[3-[4-氨基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧杂环丁烷-3-基)哌嗪-1-基]戊-2-烯腈的改性的释放制剂
CN115209899A (zh) 2019-10-14 2022-10-18 普林斯匹亚生物制药公司 通过施用(R)-2-[3-[4-氨基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧杂环丁-3-基)哌嗪-1-基]戊-2-烯腈治疗免疫性血小板减少症的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
US4721710A (en) 1988-01-26
KR840006641A (ko) 1984-12-01
FI79536B (fi) 1989-09-29
SG1989G (en) 1989-06-02
DD229407A5 (de) 1985-11-06
GR78747B (cs) 1984-10-02
PL249749A1 (en) 1985-03-12
PL139946B1 (en) 1987-03-31
IE56209B1 (en) 1991-05-22
PT77607A (fr) 1983-12-01
KR900006721B1 (ko) 1990-09-20
PL249750A1 (en) 1985-03-12
DK511383D0 (da) 1983-11-08
MA19948A1 (fr) 1984-07-01
SU1316558A3 (ru) 1987-06-07
AU2089883A (en) 1984-05-17
ES527091A0 (es) 1984-07-01
ATE22561T1 (de) 1986-10-15
FR2535721A1 (fr) 1984-05-11
EP0110755B1 (fr) 1986-10-01
NO834057L (no) 1984-05-09
SU1333237A3 (ru) 1987-08-23
JPS59161377A (ja) 1984-09-12
YU221183A (en) 1986-06-30
DE3366623D1 (en) 1986-11-06
PL244462A1 (en) 1985-02-13
PL140021B1 (en) 1987-03-31
YU184285A (en) 1986-06-30
FI834087L (fi) 1984-05-09
DD219770A5 (de) 1985-03-13
AU565519B2 (en) 1987-09-17
CS244681B2 (en) 1986-08-14
IE832581L (en) 1984-05-08
ES8406070A1 (es) 1984-07-01
DK511383A (da) 1984-05-09
PL140992B1 (en) 1987-06-30
NO159852B (no) 1988-11-07
OA07582A (fr) 1985-03-31
ZA838065B (en) 1984-06-27
YU184185A (en) 1986-06-30
NZ206177A (en) 1985-11-08
PH20421A (en) 1987-01-05
FI79536C (fi) 1990-01-10
IL70099A (en) 1987-10-20
EP0110755A1 (fr) 1984-06-13
SU1333238A3 (ru) 1987-08-23
PT77607B (fr) 1986-03-18
DD229402A5 (de) 1985-11-06
CA1221967A (en) 1987-05-19
HU191494B (en) 1987-02-27
IL70099A0 (en) 1984-01-31
FI834087A0 (fi) 1983-11-08
FR2535721B1 (cs) 1985-05-17

Similar Documents

Publication Publication Date Title
NO159852C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion.
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
NO874350L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
NO791477L (no) Fremgangsmaate ved fremstilling av nye lactam-n-eddiksyrer og deres amider
DE3160360D1 (en) 5-subsituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-ones, process for preparing them and medicaments containing them
HUT42068A (en) Process for producing new 1,4-dihydropyridine derivatives, salts and pharmaceutical compositions containing them
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
DE69100897D1 (de) N-phenyl-n-alkoxycarbonylalkyl-glycinamide, ihre herstellung und sie enthaltende medikamente.
DE69007196D1 (de) 2-Imino-3 heterocyclylamino-benzothiazoline, ihre Herstellung und sie enthaltende Arzneimittel.
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
HUT53890A (en) Fungicides comprising o-(1,2,4-triazol-1-yl)-o-phenylacetate derivatives as active ingredient and process for producing the active ingredients
JPS53124277A (en) 1-substed-(1,2-diphenylpropyl)piperazines
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.